June 2023 Legislative & Regulatory Briefing: AMCP Advocates Visit Congress for Legislative Days 2023; AMCP Submits Comments on Manufacturer Discount Program Draft Guidance; AMCP to Showcase Prescription Digital Therapeutics (PDTs) on Capitol Hill; AMCP Comments on Proposed Rules Regarding Privacy and Health Data; AMCP, Health Care Organizations Thank the Biden Administration for Relaunching the Cancer Moonshot.
May 2023 Legislative & Regulatory Briefing: AMCP’s Jennifer Mathieu Shares Tactics for Expanding Access to PDTs; ICYMI: Law CPE Sessions from AMCP 2023 Now Available on AMCP Learn; AMCP Submits Comments on Race and Ethnicity Statistical Standards; CMS Issues Final Medicare Part D DIR Reporting Guidance; Register Your Organization for the AMCP IRA Workshop Series.
April 2023 Legislative & Regulatory Briefing: AMCP Statement on Federal Court Decisions Regarding FDA Approvals; AMCP Submits Comments on the Medicare Drug Price Negotiation Program; The Equitable Community Access to Pharmacist Services Act
is Reintroduced in Congress; AMCP Comments on Preventive Services Under the ACA; AMCP, Pharmacy Organizations Send Joint Request for Telehealth Prescribing of Buprenorphine.
March 2023 Legislative & Regulatory Briefing: The Access to Prescription Digital Therapeutics Act of 2023 is Introduced; Member Benefit! Monitor COVID-19 PHE Guidance with Regulatory NewsBREAKs; AMCP Submits Comments on CMS Advance Notice for 2024; AMCP Joins Pharmacy Organizations in Letter on the COVID-19 PHE; AMCP Comments on Proposed Rule Regarding Interoperability and Prior Authorization.
February 2023 Legislative & Regulatory Briefing: AMCP CEO Susan Cantrell Reflects on PIE Act Passage; AMCP Joins Health Care Organizations in a Statement on Health Equity; AMCP Responds to Notice of Benefits and Payment Parameters for 2024; AMCP Offers Comments on Essential Health Benefits; AMCP Comments on Proposed Rule to Strengthen the Medicare Advantage and Part D Programs.
January 2023 Legislative & Regulatory Briefing: The PIE Act of 2022 Becomes Law; Member Benefit! Stay Up to Date on IRA Guidance with Regulatory NewsBREAKs; Media Coverage Captures Its Own Piece of the PIE; Reimbursement for PDTs Could Increase Access to Emerging Treatments; Registration is Now Open for AMCP 2023 in San Antonio.
December 2022 Legislative & Regulatory Briefing: The PIE Act Makes Waves in Washington D.C.; Member Benefit! Read the Latest Regulatory NewsBREAKs; AMCP CEO Susan A. Cantrell Applauds Reintroduction of the PIE Act; AMCP Joins Pharmacy Organizations in Request for Medicaid Guidance to States; AMCP's Adam Colborn Featured in Politico Pro.